SYMPOSIUM

PRAGUE
22-24 MAY 2025

Sessions

Industry sessions

Satellite Symposia offer a unique opportunity to connect with key thought leaders, access information on emerging science and innovative approaches on a wide range of current medical topics.

Considering that all Satellite Symposia will take place at the congress centre only, all presentations will be fully live and in person.

During the EADV Symposium 2025, Satellite Symposia are organised in dedicated rooms which can accommodate from 430 to 700 people, from  Thursday 22 to  Friday 23 May 2025.

Satellite Symposia Programmes

The session programme will be published here as soon as available.

Satellite Symposia and Faculty

The industry session organiser is solely responsible for keeping any of its industry sessions activities compliant with all relevant laws and regulations. EADV is not involved with in or have any control over the content, quality, organization, operation, scientific integrity of the activity and materials. EADV will not be involved in the selection of speakers, moderators and other faculty.

Access to satellite symposia

As a multidisciplinary audience will be attending the EADV Symposium 2025, please make sure to select the right category, Healthcare Professionals (HCPs) and Non-Healthcare Professionals (NON-HCPs), during the registration process.

Access to any Industry Sessions where data or research of prescription medicines is presented will be limited exclusively to Healthcare Professionals (HCPs) and Non-Member (INDUSTRY).

Industry Session organisers may limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry Session.

Official Italian Agency for AIFA Procedure

Any Italian pharmaceutical company supporting or participating in a congress abroad is subjected to authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request for authorization must be submitted within 60 days before the event’s starting date. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l.

Cristina Ghidoli
Via G. Ripamonti, 129
20134 Milan, Italy

Tel. +39 02 56601.1
e-mail: [email protected] – [email protected]

European Academy of Dermatology and Venereology - Logo Red
Facebook Instagram Linkedin Spotify Youtube
Contact
Imprint & Privacy policy
EADV Team
Cookie policy
CAREERS
Terms of use

Only trust information from our official website: eadv.org | Copyright 2024 EADV

COMING SOON

HEALTHCARE PROFESSIONAL DEFINITION

Carefully read the description below to ensure you/your delegates comply with the country’s regulations.

EADV Members are not designated as Healthcare Professionals by default

Please, define the correct status (HCP or Non-HCP) during the registration process.

Definition

According to the European Union Directive 2001/83 /EC (and amended version 2010/84/EU), the promotion of prescription only medicines should be directed solely at Healthcare Professionals or any person who is authorised to prescribe or handle them.

As a multidisciplinary audience will be attending the EADV Symposium, the delegates must  indicate if they are Healthcare Professionals (HCP) or Non-Healthcare Professionals (Non-HCP) to ensure compliance with these regulations.

Access to the different areas and sessions of the Symposium depends on the status as Healthcare Professional or as Non-Healthcare Professional. 

The Pharmaceutical Research Based Industry Malta Association (2014) defines HCP as:

“Any member of the medical, dental, pharmacy or nursing professions or any other person who in the course of his or her professional activities may prescribe, purchase, supply or administer a medicinal product. “

Industry sessions and advertising

Sections of the code also relevant to a congress held in Malta:

“Any such promotional material (excluding promotional aids) is accompanied by a suitable statement indicating countries in which the product is registered and makes clear that the product or use is not registered locally, and any such promotional material which refers to the prescribing information (indications, warnings etc.) authorized in a country or countries where the medicinal product is registered should be accompanied by an explanatory statement indicating that registration conditions differ internationally.”

Satellite Symposia presenting data on the development, research or other issues related to prescription medicine can be restricted to Healthcare Professionals and Industry Participants only upon indication provided by the Industry Session Organizer. All promotional materials and marketing aids related to these industry sessions should be strictly limited to HCPs only.

Industry Session organisers could limit participation to certain representative groups independently from the EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session. The organising company reserves the right to refuse single categories, in particular if not adequately related to the objective and purpose of the session.

The industry session organizer is responsible for the compliance of the session.

Other categories

STUDENTS are NOT considered as Healthcare Professionals under the current guidelines and will be automatically classified as NON-HEALTHCARE PROFESSIONALS.

PATIENT ASSOCIATION REPRESENTATIVES must indicate whether they are Healthcare Professionals or not at registration.